<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> represent particularly challenging <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> that arise from a large spectrum of genetic events resulting in a disease characterized by a range of different presentations and outcomes </plain></SENT>
<SENT sid="1" pm="."><plain>Despite efforts to classify and identify the key genetic events, little improvement has been made in therapies that will increase patient survival </plain></SENT>
<SENT sid="2" pm="."><plain>Animal models represent powerful tools to model and study human diseases and are useful pre-clinical platforms </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to enforced expression of candidate oncogenes, gene inactivation has allowed the consequences of the genetic effects of human <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> to be studied in mice </plain></SENT>
<SENT sid="4" pm="."><plain>This review aims to examine the animal models expressing <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>-associated genes that are currently available and to highlight the most appropriate model to phenocopy <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> disease and its risk of transformation to <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> </plain></SENT>
</text></document>